Vertex Pharmaceuticals
Biotech · 12 tracked clinical trials
Clinical Pipeline
| Trial | Phase | Status | Indication |
|---|---|---|---|
| NCT07624526 | PHASE4 | NOT_YET_RECRUITING | Knee Arthritis, Knee Osteoarthritis |
| NCT07463430 | PHASE4 | ENROLLING_BY_INVITATION | Pain, Acute Postoperative, Breast Disease |
| NCT05422222 | PHASE3 | ACTIVE_NOT_RECRUITING | Cystic Fibrosis |
| NCT05844449 | PHASE3 | ENROLLING_BY_INVITATION | Cystic Fibrosis |
| NCT06460506 | PHASE3 | ACTIVE_NOT_RECRUITING | Cystic Fibrosis |
| NCT04786262 | PHASE3 | RECRUITING | Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia |
| NCT05477563 | PHASE3 | RECRUITING | Beta-Thalassemia, Thalassemia, Hematologic Diseases |
| NCT07204275 | PHASE2, PHASE3 | RECRUITING | Primary Membranous Nephropathy |
| NCT05312879 | PHASE2, PHASE3 | RECRUITING | Proteinuric Kidney Disease |
| NCT07501702 | PHASE2 | RECRUITING | Myasthenia Gravis, Generalized |
| NCT06926621 | PHASE2 | ENROLLING_BY_INVITATION | Myotonic Dystrophy Type 1 (DM1) |
| NCT07161037 | PHASE2 | RECRUITING | Autosomal Dominant Polycystic Kidney Disease (ADPKD) |